The Phenylketonuria Treatment Market To Witness A Healthy Reverberation BetweenPosted by Ashish on April 6th, 2021 Phenylketonuria (PKU) is an inherited disorder caused by excess of phenylalanine in the blood, which can lead to severe intellectual disabilities. There is no cure for phenylketonuria as yet, and dietary management is the only option to maintain the phenylalanine level in the body. Untreated infants with PKU tend to have unusually light eye, skin, and hair colour due to excess of phenylalanine levels interfering with melanin. Neurological symptoms such as seizures, abnormal muscle movement, tremors, or involuntary movement are some of the symptoms mainly observed in such patients. Rising prevalence of phenylketonuria among newborns and surging demand for novel formulations to treat the disease have led to increased opportunities for market players. Stakeholders are investing more in research & development for novel treatment solutions within the nutraceutical industry. Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/14410 Companies covered in Phenylketonuria Treatment Market Report
Like it? Share it!More by this author |